Selon les derniers rapports financiers de BioCryst Pharmaceuticals , la dette totale de l'entreprise est de 0.77 Milliard d'euros. La dette totale d'une entreprise est la somme de toutes les dettes courantes et non courantes.
Année | Dette totale | Changement |
---|---|---|
2023-12-31 | €0.74 Md | 7.99% |
2022-12-31 | €0.69 Md | 31.95% |
2021-12-31 | €0.52 Md | 130.52% |
2020-12-31 | €0.22 Md | 200.71% |
2019-12-31 | €75.56 M | 39.83% |
2018-12-31 | €54.04 M | 18.49% |
2017-12-31 | €45.6 M | -10.71% |
2016-12-31 | €51.07 M | 85.05% |
2015-12-31 | €27.6 M | 11.9% |
2014-12-31 | €24.66 M | 13.55% |
2013-12-31 | €21.72 M | -4.22% |
2012-12-31 | €22.67 M | -1.82% |
2011-12-31 | €23.1 M | |
2000-12-31 | €0.01 M | |
1997-12-31 | €0.08 M | -66.67% |
1996-12-31 | €0.25 M |